A review published in JAMA Internal Medicine found that women have less than 50% — some down to 20% — median trial representation in common cardiovascular and orthopedic clinical trials.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,